Pyxis Oncology to Present Phase 1 MICVO Data at EORTC-NCI-AACR Symposium
Pyxis Oncology says it will present Phase 1 monotherapy data for micvotabart pelidotin at the symposium.
Pyxis Oncology says it will present Phase 1 monotherapy data for micvotabart pelidotin at the symposium.